Publications by authors named "Giuseppina Improta"

Claim this Profile
Mutant Allele Frequency in Melanoma and its Correlation With Clinicopathological Characteristics.
Angela Zupa, Giulia Vita, Ludmila Carmen Omer, Giovanni Calice, Raffele Conca, Giuseppina Improta

Anticancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?
Giuseppina Improta, Giulia Vita, Alfredo Tartarone, Giovanni Calice, Ludmila Carmen Omer

Anticancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Elisa Baldelli, K Alex Hodge, Guido Bellezza, Neil J Shah, Guido Gambara, Giuseppina Improta

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.
Giuseppina Improta, Angela Pettinato, Estrid Høgdall, Giuseppe Santeusanio, Simona Vatrano

Appl Immunohistochem Mol Morphol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.
Giuseppina Improta, Angela Zupa, Maria Iole Natalicchio, Lorenza Sisinni, Anna Marinaccio

Med Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel Node Biopsy in Melanoma: Lessons Learned From Different Positivity Rates From Different Hospitals.
Gerardo Ferrara, Giuseppina Improta

Ann Surg· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.
Giuseppina Improta, Cathrin Ritter, Angela Pettinato, Valeria Vasta, David Schrama

J Cancer Res Clin Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.
Gian Franco Zannoni, Giuseppina Improta, Angela Pettinato, Chiara Brunelli, Giancarlo Troncone

J Clin Pathol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermotropic progression of melanoma during therapy with vemurafenib and trametinib.
Gerardo Ferrara, Veronica Cacitti, Giuseppina Improta, Giovanni Lo Re, Maria Teresa Corradin

J Am Acad Dermatol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases.
Gian Franco Zannoni, Giuseppina Improta, Marco Petrillo, Angela Pettinato, Giovanni Scambia

Oncol Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance.
Giuseppina Improta, Angela Pettinato, Stefania Gieri, Giuseppa Scandurra, Wojciech Skovrider-Ruminski

Oncol Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New developments in the management of advanced melanoma - role of pembrolizumab.
Giuseppina Improta, Isabella Leone, Marco Donia, Stefania Gieri, Giuseppe Pelosi

Onco Targets Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA in ovarian clear cell carcinoma.
Gian Franco Zannoni, Giuseppina Improta, Filippo Fraggetta

Hum Pathol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral malignant melanoma: A report of two cases with BRAF molecular analysis.
Pier Francesco Soma, Angela Pettinato, Anna Maria Agnone, Claudio Donia, Giuseppina Improta

Oncol Lett· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.
Gian Franco Zannoni, Giuseppina Improta, Gaia Chiarello, Angela Pettinato, Marco Petrillo

Virchows Arch· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma.
Maria Iole Natalicchio, Giuseppina Improta, Angela Zupa, Olga Elisabetta Cursio, Emanuela Stampone

Future Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSA nadir and outcome in 100 patients with pT3b prostate cancer.
Pietro Pepe, Giuseppina Improta, Filippo Fraggetta, Carmela Emmanuele, Vittorio Simeon

Anticancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic consideration for sinonasal Wegener's granulomatosis clinically mistaken for carcinoma.
Cristina La Rosa, Carmela Emmanuele, Maria Grazia Tranchina, Massimo Ippolito, Sebastiano Cosentino, Giuseppina Improta

Case Rep Otolaryngol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib.
Alfredo Tartarone, Chiara Lazzari, Rosa Lerose, Vincenza Conteduca, Giuseppina Improta

Lung Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological insights into BRAF mutations in melanoma patient: Not mere therapeutic targets.
Giuseppina Improta, Giuseppe Pelosi, Elena Tamborini, Marco Donia, Mario Santinami

Oncoimmunology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate needle biopsy: what we do and what should be improved.
Filippo Fraggetta, Pietro Pepe, Giuseppina Improta, Francesco Aragona, Maurizio Colecchia

Anal Quant Cytopathol Histpathol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity.
Giuseppina Improta, Angela Zupa, Luciana Possidente, Alfredo Tartarone, Piernicola Pedicini

Oncol Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer.
Piernicola Pedicini, Lidia Strigari, Rocchina Caivano, Alba Fiorentino, Giorgia Califano, Giuseppina Improta

J Appl Clin Med Phys· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature.
Giuseppina Gallucci, Alfredo Tartarone, Carlo Gabriele Tocchetti, Anna Maria Bochicchio, Mariarosa Coccaro, Giuseppina Improta

Future Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot characterization of human lung NSCLC by protein pathway activation mapping.
Angela Zupa, Giuseppina Improta, Alessandra Silvestri, Elisa Pin, Jianghong Deng

J Thorac Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis